Euroapi SA (XPAR:EAPI) Share Price

Company Profile

Business description
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers. Geographically, the company generates maximum revenue from Europe, followed by North America, Asia-Pacific, and the Rest of the world.
Contact
15 rue Traversiere
Paris75012
FRA
T: +33 189206200
https://www.euroapi.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
3,430

Recommended

Morningstar’s Greg Warren says Berkshire may have little choice but to take a hard look at this huge potential acquisition.

Joseph Taylor | 05 August 2025

A key provision of the new award is that Musk must remain in a senior leadership position at Tesla.

Seth Goldstein, CFA | 04 August 2025

This undervalued miner is unappreciated by the market.

Esther Holloway | 04 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,019.70	97.70	1.10%
CAC 40	7,632.01	85.85	1.14%
DAX 40	23,757.69	331.72	1.42%
Dow JONES (US)	44,173.64	585.06	1.34%
FTSE 100	9,128.30	59.72	0.66%
HKSE	24,784.90	51.45	0.21%
NASDAQ	21,053.58	403.45	1.95%
Nikkei 225	40,489.44	198.74	0.49%
NZX 50 Index	12,781.89	97.85	0.77%
S&P 500	6,329.94	91.93	1.47%
S&P/ASX 200	8,759.40	95.70	1.10%
SSE Composite Index	3,593.89	10.58	0.30%